BioMed Research International

BioMed Research International / 2020 / Article

Retraction | Open Access

Volume 2020 |Article ID 2451249 | https://doi.org/10.1155/2020/2451249

BioMed Research International, "Retracted: Apoptosis and Molecular Targeting Therapy in Cancer", BioMed Research International, vol. 2020, Article ID 2451249, 1 page, 2020. https://doi.org/10.1155/2020/2451249

Retracted: Apoptosis and Molecular Targeting Therapy in Cancer

Received11 Jul 2020
Accepted14 Jul 2020
Published30 Aug 2020

BioMed Research International has retracted the article titled “Apoptosis and Molecular Targeting Therapy in Cancer” [1]. The article was found to contain a substantial amount of material from previously published articles, including the following sources:

(i) John C Reed. “Apoptosis-targeted therapies for cancer”, Cancer Cell, 2003. 10.1016/S1535-6108(02)00241-6. [2] (Not Cited)

(ii) DB Longley, PG Johnston. “Molecular mechanisms of drug resistance”, The Journal of Pathology, 2005. 10.1002/path.1706. [3] (Not Cited)

(iii) Suparna Mazumder, Dragos Plesca and Alexandru Almasan. “A Jekyll and Hyde Role of Cyclin E in the Genotoxic Stress Response: Switching from Cell Cycle Control to Apoptosis Regulation”, Cell Cycle, 06/15/2007. 10.4161/cc.6.12.4432. [4] (Not Cited)

(iv) Plati, Jessica, Octavian Bucur, and Roya Khosravi-Far. “Apoptotic cell signaling in cancer progression and therapy”, Integrative Biology, 2011. DOI: 10.1039/C0IB00144A. [5] (Not Cited)

(v) C. Gullo, M. Au, G. Feng, and G. Teoh, “The biology of Ku and its potential oncogenic role in cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1765, no. 2, pp. 223–234, 2006. 10.1016/j.bbcan.2006.01.001. [6] (Cited as reference 222)

References

  1. M. Hassan, H. Watari, A. AbuAlmaaty, Y. Ohba, and N. Sakuragi, “Apoptosis and Molecular Targeting Therapy in Cancer,” BioMed Research International, vol. 2014, Article ID 150845, 23 pages, 2014. View at: Publisher Site | Google Scholar
  2. J. C. Reed, “Apoptosis-targeted therapies for cancer,” Cancer Cell, vol. 3, no. 1, pp. 17–22, 2003. View at: Publisher Site | Google Scholar
  3. D. B. Longley and P. G. Johnston, “Molecular Mechanisms of Drug Resistance,” The Journal of Pathology, vol. 205, no. 2, pp. 275–292, 2005. View at: Publisher Site | Google Scholar
  4. S. Mazumder, D. Plesca, and A. Almasan, “A Jekyll and Hyde Role of Cyclin E in the Genotoxic Stress Response: Switching from Cell Cycle Control to Apoptosis Regulation,” Cell Cycle, vol. 6, no. 12, pp. 1436–1441, 2007. View at: Publisher Site | Google Scholar
  5. J. Plati, O. Bucur, and R. Khosravi-Far, “Apoptotic cell signaling in cancer progression and therapy,” Integrative Biology, vol. 3, no. 4, pp. 279–296, 2011. View at: Publisher Site | Google Scholar
  6. C. Gullo, M. Au, G. Feng, and G. Teoh, “The biology of Ku and its potential oncogenic role in cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1765, no. 2, pp. 223–234, 2006. View at: Publisher Site | Google Scholar

Copyright © 2020. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views832
Downloads300
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.